| PEER-REVIEWED RESEARCH |
Chintan Patel, Sanjay Bandyopadhyay, Gayatri Patel
Research into peginterferon alfa-2b’s degradation pathways suggest that drug substance be immediately and continuously converted to drug product when the material is in liquid form.
/ read more /
| MANUFACTURING |
Jennifer Markarian
Establishing OEL data and ensuring appropriate engineering controls are crucial aspects of safe handling.
/ read more /
Hallie Forcinio
Advances in fill/finish for parenteral packaging address demands for efficiency and product safety.
/ read more /
| QUALITY/REGULATIONS |
Robert Glasser
Software systems can help validate pharmaceutical manufacturing.
/ read more /
Ajay Babu Pazhayatil, Marzena Ingram, Naheed Sayeed
Production and process controls, organization and personnel were the top problems found, while packaging and labelling citations increased in 2017 and 2018.
/ read more /
Jeremy Drummond
Changing regulatory guidance on generic topical products is expected to lead to an increase in the number of market approvals in the near future.
/ read more /
| ANALYTICS |
Felicity Thomas
In this article, experts discuss the fundamentals of dissolution testing and highlight the challenges that are surfacing as a result of the increasing numbers of poorly soluble molecules entering the development pipeline. / read more /
Christopher Burgess
Using the central limit theorem concerning the distribution of means allows one to justify the assumption of the normal distribution. / read more /
| SUPPLY CHAIN |
Jennifer Markarian
Automated, electronic systems for raw materials tracking improve efficiency and prevent mistakes in biopharma manufacturing. / read more /
| OUTSOURCING |
Susan Haigney
Industry experts discuss the challenges and regulations of setting up a CGMP-compliant stability testing programme.
/ read more /
| EDITOR'S COMMENT |
Felicity Thomas
With no plausibly approvable deal on the table in the UK government at the moment, it is possible that Brexit could be extended even further. / read more /
| EUROPEAN REGULATORY WATCH |
Sean Milmo
A new European Commission is likely, with the support of a new European Parliament, to give a higher profile to healthcare and pharmaceutical matters during its five years in office. / read more /
|